Press Releases

    • September 14, 2023

    Nemaura Medical Provides Update on Nasdaq Compliance Status and Process

    LOUGHBOROUGH, Sept. 14, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc.(Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    Read more
    September 14, 2023

    Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program

    LOUGHBOROUGH, Sept. 13, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    Read more
    September 12, 2023

    Nemaura Medical Announces Participation at HLTH 2023, Las Vegas

    LOUGHBOROUGH, Sept. 12, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company...

    Read more
    September 11, 2023

    Nemaura Medical Completes 100 Patient Study for sugarBEAT® 24-hour Wear and Reports Interim Results

    LOUGHBOROUGH, Sept. 11, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology...

    Read more
    August 17, 2023

    Nemaura Medical Announces SFDA Approval of sugarBEAT®

    Loughborough, England, Aug. 17, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    August 14, 2023

    Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update

    Loughborough, England, Aug. 14, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    August 11, 2023

    Nemaura Medical Secures $6.5m in Non-Dilutive Funding

    Loughborough, England, Aug. 11, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on...

    Read more
    July 14, 2023

    Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023

    Loughborough, England, July 14, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    June 27, 2023

    Nemaura Medical Scales-Up Pilot Expansion of proBEAT™; 56 Corporations in the U.S. Signed Up for Pilots in June 2023

    LOUGHBOROUGH, June 27, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology...

    Read more
    June 23, 2023

    Nemaura Medical to Participate at the Collision Conference in Toronto June 26-29, 2023

    LOUGHBOROUGH, June 22, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on...

    Read more